Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hulin

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Annales De Medecine Interne|January 1, 1992
[Bone metastasis of prostatic origin with pseudo-sarcomatous form. Apropos of a case with monomelic localization]J Leone, C Hulin, D Logeart, et al.
Journal of Clinical Pharmacy and Therapeutics|January 5, 2011
Management of relapsed or refractory multiple myeloma in French hospitals and estimation of associated direct costs: a multi-centre retrospective cohort studyX Armoiry, F Fagnani, L Benboubker, et al.
Presse Medicale (Paris, France : 1983)|August 1, 2002
[Granulocyte sarcoma of the pancreas without extra-pancreatic location]S Dimicoli, P Feugier, P Delaby, et al.
Annales De Dermatologie Et De Venereologie|May 21, 2016
[Mucinous nevus of late onset]A Walter Lepage, É Frouin, A Junca, et al.
Leukemia|February 16, 2011
Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed multiple myelomaP Moreau, F Cavallo, X Leleu, et al.
Annales De Biologie Clinique|February 15, 2001
[Diagnosis of lymphoid hemopathy at the time of the diagnosis of cryoglobulinemia]A Fohlen-Walter, J F Lesesve, C Jacob, et al.
La Revue De Medecine Interne|September 10, 1999
[Prevalence of antiphospholipid antibodies in Horton's disease and in polymyalgia rheumatica]C Hulin, E Hachulla, U Michon-Pasturel, et al.
Leukemia|January 15, 2010
Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasoneH Avet-Loiseau, J Soulier, J-P Fermand, et al.
Leukemia & Lymphoma|September 16, 2011
Efficacy of bendamustine in relapsed/refractory myeloma patients: results from the French compassionate use programG Damaj, F Malard, C Hulin, et al.
La Revue De Medecine Interne|August 11, 2015
[Pomalidomide for multiple myeloma]G Fouquet, M Macro, O Decaux, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Annales De Medecine Interne|January 1, 1992
[Bone metastasis of prostatic origin with pseudo-sarcomatous form. Apropos of a case with monomelic localization]J Leone, C Hulin, D Logeart, et al.
Journal of Clinical Pharmacy and Therapeutics|January 5, 2011
Management of relapsed or refractory multiple myeloma in French hospitals and estimation of associated direct costs: a multi-centre retrospective cohort studyX Armoiry, F Fagnani, L Benboubker, et al.
Presse Medicale (Paris, France : 1983)|August 1, 2002
[Granulocyte sarcoma of the pancreas without extra-pancreatic location]S Dimicoli, P Feugier, P Delaby, et al.
Annales De Dermatologie Et De Venereologie|May 21, 2016
[Mucinous nevus of late onset]A Walter Lepage, É Frouin, A Junca, et al.
Leukemia|February 16, 2011
Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed multiple myelomaP Moreau, F Cavallo, X Leleu, et al.
Annales De Biologie Clinique|February 15, 2001
[Diagnosis of lymphoid hemopathy at the time of the diagnosis of cryoglobulinemia]A Fohlen-Walter, J F Lesesve, C Jacob, et al.
La Revue De Medecine Interne|September 10, 1999
[Prevalence of antiphospholipid antibodies in Horton's disease and in polymyalgia rheumatica]C Hulin, E Hachulla, U Michon-Pasturel, et al.
Leukemia|January 15, 2010
Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasoneH Avet-Loiseau, J Soulier, J-P Fermand, et al.
Leukemia & Lymphoma|September 16, 2011
Efficacy of bendamustine in relapsed/refractory myeloma patients: results from the French compassionate use programG Damaj, F Malard, C Hulin, et al.
La Revue De Medecine Interne|August 11, 2015
[Pomalidomide for multiple myeloma]G Fouquet, M Macro, O Decaux, et al.
Pageof 5